-
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Rating of "Moderate Buy" from Analysts
来源: Buzz FX / 02 2月 2025 02:56:10 America/New_York
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat February 2, 2025 Share Link copied to clipboard. Shares of Ionis Pharmaceuticals, Inc.
Read more...